Merriman Curhan Ford initiates coverage on Novavax (Nasdaq: NVAX) with a Buy rating and $6-$8 price target range.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE